News

Eli Lilly lands an $870 million pact with Camurus to build long-acting obesity treatments, tapping FluidCrystalslow-release ...
Merck, as it prepares a new version of its cancer blockbuster Keytruda, gets a boost in its patent dispute with Halozyme ...
Enter: vitamin patches. Companies like Barriere, The Good Patch, and Alan have introduced chic “sticker vitamins” that you ...
Myriad Markets users are putting their money where their mouths are on the Musk/Trump schism, Ethereum's price, the French ...
The rapid addition of small interfering RNA therapy to usual care after a recent ACS helps more patients achieve recommended ...
I’ve had a good season, I'm enjoying myself at Bristol, but you are right: I want to be ambitious. I want to play in the top ...